Home > Insider Trading > Filing (0001209191-20-031881)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
873303	Sarepta Therapeutics Inc.	SRPT	Pharmaceutical Preparations (2834)	930797222

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1492766	Rudolf Lennart Hans Wigzell	215 First Street, Suite 415 Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-20	5,000	$10.08	18,792	No	4	M	Direct
Common Stock	Disposition	2020-05-20	2,100	$149.62	16,692	No	4	S	Direct
Common Stock	Disposition	2020-05-20	2,046	$151.22	14,646	No	4	S	Direct
Common Stock	Disposition	2020-05-20	854	$151.77	13,792	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Oprion (right to buy)	Disposition	2020-05-20	5,000	$0.00	5,000	$10.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-08-23	2022-08-23	No	4	M	Direct

Footnotes

The shares were sold in transactions at prices ranging from $149.11 to $149.89, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The shares were sold in transactions at prices ranging from $150.62 to $151.62, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The shares were sold in transactions at prices ranging from $151.67 to $151.75, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.